C.I. Medical Co.,Ltd. (TYO:3540)
898.00
-5.00 (-0.55%)
May 23, 2025, 3:30 PM JST
C.I. Medical Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 22, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 45,149 | 45,949 | 41,999 | 50,599 | 46,350 | 63,100 | Upgrade
|
Market Cap Growth | 5.13% | 9.40% | -17.00% | 9.17% | -26.55% | 104.21% | Upgrade
|
Enterprise Value | 51,343 | 60,063 | 57,074 | 56,503 | 41,240 | 59,170 | Upgrade
|
Last Close Price | 903.00 | 919.00 | 828.45 | 992.12 | 904.30 | 1223.14 | Upgrade
|
PE Ratio | 6.11 | 7.33 | 20.17 | 20.07 | 16.44 | 21.61 | Upgrade
|
Forward PE | 13.28 | 10.86 | 15.56 | 19.36 | 15.37 | 23.04 | Upgrade
|
PS Ratio | 0.58 | 0.68 | 0.92 | 1.18 | 1.13 | 1.69 | Upgrade
|
PB Ratio | 1.60 | 1.68 | 2.09 | 2.77 | 2.90 | 4.59 | Upgrade
|
P/TBV Ratio | 1.76 | 1.88 | 2.30 | 3.07 | 3.04 | 4.83 | Upgrade
|
P/FCF Ratio | - | 9.32 | - | - | - | 17.05 | Upgrade
|
P/OCF Ratio | - | 7.47 | - | 35.91 | 29.37 | 15.17 | Upgrade
|
EV/Sales Ratio | 0.66 | 0.89 | 1.25 | 1.32 | 1.00 | 1.58 | Upgrade
|
EV/EBITDA Ratio | 9.22 | 12.43 | 14.22 | 12.88 | 8.47 | 11.90 | Upgrade
|
EV/EBIT Ratio | 17.66 | 24.07 | 19.08 | 14.15 | 9.12 | 12.58 | Upgrade
|
EV/FCF Ratio | - | 12.19 | - | - | - | 15.99 | Upgrade
|
Debt / Equity Ratio | 0.30 | 0.77 | 0.85 | 0.39 | - | - | Upgrade
|
Debt / EBITDA Ratio | 1.54 | 4.39 | 4.28 | 1.62 | - | - | Upgrade
|
Debt / FCF Ratio | - | 4.30 | - | - | - | - | Upgrade
|
Asset Turnover | 1.70 | 1.29 | 1.27 | 1.71 | 2.12 | 2.28 | Upgrade
|
Inventory Turnover | 4.41 | 3.82 | 4.25 | 4.66 | 5.06 | 4.78 | Upgrade
|
Quick Ratio | 0.73 | 0.40 | 0.41 | 0.54 | 2.13 | 1.99 | Upgrade
|
Current Ratio | 1.74 | 0.92 | 0.86 | 1.23 | 4.11 | 3.35 | Upgrade
|
Return on Equity (ROE) | 31.05% | 26.51% | 10.92% | 14.74% | 18.97% | 23.65% | Upgrade
|
Return on Assets (ROA) | 3.81% | 2.98% | 5.21% | 9.96% | 14.57% | 17.92% | Upgrade
|
Return on Capital (ROIC) | 4.73% | 3.63% | 5.96% | 12.07% | 19.02% | 23.80% | Upgrade
|
Return on Capital Employed (ROCE) | 8.40% | 8.30% | 14.50% | 21.30% | 27.60% | 33.20% | Upgrade
|
Earnings Yield | 16.36% | 13.64% | 4.96% | 4.98% | 6.08% | 4.63% | Upgrade
|
FCF Yield | - | 10.73% | -21.63% | -15.69% | -2.70% | 5.87% | Upgrade
|
Dividend Yield | 1.39% | 1.36% | 0.61% | 0.51% | 0.62% | 0.48% | Upgrade
|
Payout Ratio | - | 4.02% | 12.10% | 11.19% | 20.71% | 5.14% | Upgrade
|
Buyback Yield / Dilution | -0.01% | -0.01% | - | 0.01% | 0.00% | 0.00% | Upgrade
|
Total Shareholder Return | 1.36% | 1.35% | 0.61% | 0.52% | 0.62% | 0.48% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.